Does oxidative stress cause acinar cell injury and reduced pancreatic enzyme secretion?

The relationship between oxidative stress, cellular injury, and the decline of pancreatic function is well-established in clinical and mechanistic research. In patients with chronic pancreatitis, a persistent imbalance between reactive oxygen species (ROS) and antioxidant defenses serves as a primary driver of tissue destruction and functional loss.

Mechanistic explanations

• Acinar Cell Injury: Oxidative stress initiates damage in pancreatic acinar cells through lipid peroxidation (LPO). ROS abstract hydrogens from membrane phospholipids, creating reactive aldehydes like malondialdehyde (MDA). This disrupts the membranes of critical organelles, including the endoplasmic reticulum and zymogen granules, leading to the premature activation of digestive enzymes within the cell.
• DNA Damage and Apoptosis: Lipid peroxides can translocate to the nucleus, inducing 8-hydroxy-2'-deoxyguanosine (8-OHdG), a hallmark of oxidative DNA damage. This process triggers apoptotic pathways via caspase-3 and p53, leading to programmed cell death.
• Fibrotic Progression: ROS activate pancreatic stellate cells (PSCs), transforming them into myofibroblast-like cells. These activated PSCs are responsible for the excessive deposition of extracellular matrix proteins, which gradually replaces functional acinar tissue with non-functional fibrous scar tissue.

Clinical and effectiveness evidence

• Oxidative Imbalance: Clinical studies consistently show that patients with chronic pancreatitis have elevated markers of lipid peroxidation and significantly reduced antioxidant capacity, including lower levels of glutathione, superoxide dismutase (SOD), and glutathione peroxidase (GPx).
• Prevalence of Functional Loss: Longitudinal data indicate that exocrine pancreatic insufficiency (EPI) affects approximately 46.5% to 65.8% of patients with chronic pancreatitis. The prevalence of reduced enzyme secretion increases significantly as the disease duration and stage advance.
• Diagnostic Indicators: The reduction in enzyme secretion is clinically measured using fecal elastase-1 (FE-1). Levels below 200 μg/g are established indicators of reduced secretion and the presence of EPI.

Clinical implications

• Parenchymal Atrophy: The progression from recurrent inflammation to chronic fibrosis results in irreversible parenchymal atrophy. This directly reduces the pancreas's ability to synthesize and secrete essential enzymes such as lipase, amylase, and proteases.
• Ductal Obstruction: In addition to cellular loss, the development of strictures, protein plugs, and calcified stones during disease progression physically impairs the delivery of remaining enzymes to the duodenum, further exacerbating malabsorption.

Bottom line

Oxidative stress is a critical factor in chronic pancreatitis that causes direct acinar cell injury and drives the fibrotic replacement of functional tissue. This process leads to a significant and measurable reduction in exocrine enzyme secretion, often resulting in clinical pancreatic insufficiency.